Abstract

Estradiol 0.1% Vaginal Solution

Author(s): Allen Loyd V Jr

Issue: Sep/Oct 2008 - Veterinary Compounding

Page(s): 450

Download in electronic PDF format for $75

Abstract

A formulation for preparing Estradiol 0.1% Vaginal Solution. Includes ingredients, method of preparation, discussion, and references for the compounding pharmacist.

Related Keywords

Related Categories

Printer-Friendly Version

Related Articles from IJPC

Issue/Page View/Buy	Title/Author (Click for Abstract / Details / Purchase)
Jan/Feb 2024 Pg. 58	Estradiol 0.1% Vaginal Solution Author(s): Allen Loyd V Jr
Sep/Oct 2008 Pg. 450	Estradiol 0.1% Vaginal Solution Author(s): Allen Loyd V Jr
Nov/Dec 2018 Pg. 456-465	Compounding to Prevent and Treat Dysbiosis of the Human Vaginal Microbiome Author(s): Riepl Mike
Nov/Dec 2009 Pg. 556	Gentian Violet Vaginal Suppositories Author(s): Allen Loyd V Jr
Nov/Dec 2016 Pg. 447-454	Menopausal Symptom Relief and Side Effects Experienced by Women Using Compounded Bioidentical Hormone Replacement Therapy and Synthetic Conjugated Equine Estrogen and/or Progestin Hormone Replacement Therapy, Part 2 Author(s): Deleruyelle Laura J
Jul/Aug 2009 Pg. 338	Mupirocin 1% (20-mg) Vaginal Suppository Author(s): Allen Loyd V Jr
Jan/Feb 2001 Pg. 52-54	Using Serum Hormone Analysis to Develop Hormone Replacement Therapy Regimens - Part 2 Author(s): Ford Gina, Garcia Lea
Mar/Apr 2023 Pg. 108-112	Vulvovaginal Symptoms in a Postmenopausal Woman: A Case Study Author(s): Lima Ramona, Gonzalez Mark A, Urwin Craig, Jean Linda, Carvalho Maria, Banov Fabiana
Jul/Aug 2016 Pg. 322	Nystatin 100,000-units Vaginal Inserts Author(s): Allen Loyd V Jr
Jan/Feb 2019 Pg. 77-81	Ex Vivo Evaluation of Intravaginal Progesterone and Testosterone to Treat the Luteal-phase Deficiency and Vaginal Atrophy Author(s): Laque Larissa C, Raposo Nádia RB, Fernandes Brandão Marcos Antônio, de Oliveira Ferreira Anderson, Polonini Hudson C
May/Jun 2018 Pg. 196-202	Case Report of a Human Papillomavirus Infection Treated with Green Tea Extract and Curcumin Vaginal Compounded Medications Author(s): Agbi Kelechi E, Hover Sara, Carvalho Maria
Jul/Aug 2009 Pg. 334	Clindamycin 100-mg Vaginal Suppositories Author(s): Allen Loyd V Jr
Jul/Aug 2003 Pg. 250-256	A Perspective on HRT for Women: Picking Up the Pieces After the Women's Health Initiative Trial - Part 1 Author(s): Gillson George R, Zava David T
Sep/Oct 2016 Pg. 359-364	Menopausal Symptom Relief and Side Effects Experienced by Women Using Bioidentical Hormone Replacement Therapy and Synthetic Conjugated Equine Estrogen and/or Progestin Hormone Replacement Therapy, Part 1 Author(s): Deleruyelle Laura J
May/Jun 2018 Pg. 190-195	Establishing a Rationale for Compounding Hormone Replacement Therapy Author(s): Biundo Bruce
Jan/Feb 2024 Pg. 22-27	Establishing a Rationale for Compounding Hormone Replacement Therapy Author(s): Biundo Bruce
Mar/Apr 2012 Pg. 110-114	Bilateral Areolar Hyperpigmentation Following Transdermal Administration of Compounded Hormone Replacement Therapy Author(s): Griffee Chris, Delano Amy
Nov/Dec 2018 Pg. 504-511	Physical and Chemical Stability of Estriol 0.025% to 1% Vaginal Creams (VersaBase) Author(s): Ip Kendice, Shan Ashley, Yan Wei, Banov Daniel
Sep/Oct 2001 Pg. 375	Estriol 2-mg/g with Estradiol 0.5-mg/g Vaginal Cream Author(s): Allen Loyd V Jr
Jan/Feb 1998 Pg. 48	Estradiol 1-mg Vaginal Suppositories Author(s): Allen Loyd V Jr